| 1. |
World Health Organization. Global tuberculosis report 2020 [EB/OL] [2020-10-14]. https://www.who.int/teams/global-tuberculosis-programme/tb-reports.
|
| 2. |
中華人民共和國國國務院辦公廳. 國務院辦公廳關于印發“十三五”全國結核病防治規劃的通知. http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm.
|
| 3. |
Zhang L, Wang F, Wang L, et. al Prevalence of chronic kidney disease in China: across -sectional survey. Lancet, 2012, 379(9818): 815-822.
|
| 4. |
National Institute for Health and Care Excellence. Guidelines for tuberculosis [EB/OL]. (2016-05-01) [2016-09-12].
|
| 5. |
World Health Organization. Latent tuberculosis infection [EB/OL]. [2016-09-12].
|
| 6. |
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266.
|
| 7. |
中國防癆協會. 耐藥結核病化學治療指南(2019). 中國防癆雜志, 2019, 41(10): 1025-1073.
|
| 8. |
中華醫學會結核病學分會. 抗結核藥物性肝損傷診治指南(2019 年版). 中華結核和呼吸雜志, 2019, 42(5): 343-356.
|
| 9. |
Ostermann M, Palchaudhuri P, Riding A, et al. Incidence of tuberculosis is high in chronic kidney disease patients in South East England and drug resistance common. Ren Fail, 2016, 38(2): 256-261.
|
| 10. |
The National Collaborating Center for Chronic Conditions. Tuberculosis Clinical diagnosis and management of tuberculosis and measures for its prevention and control. London: Royal College of Physicians, 2006.
|
| 11. |
袁發煥, 光麗霞, 趙生家. 1069 例慢性腎衰患者合并結核病的臨床對比研究. 中國現代醫學雜志, 2004, 14(20): 1-5, 8.
|
| 12. |
Yuan FH, Guang LX, Zhao SJ. Clinical comparisons of 1 498 chronic renal failure patients with and without tuberculosis. Ren Fail, 2005, 27: 149-153.
|
| 13. |
張訓, 侯凡凡, 魏冬梅, 等. 慢性腎功能衰竭接受腎替代治療病人并發結核病. 中華內科學雜志, 1995, 34(10): 666-669.
|
| 14. |
葉文玲, 李學旺, 李航. 慢性腎功能衰竭血液透析患者合并結核感染的診治. 中國醫學院學報, 2001, 23(5): 535-536.
|
| 15. |
上海慢性腎臟病早發現及規范化診治與示范項目專家組, 高翔, 梅長林. 慢性腎臟病篩查診斷及防治指南. 中國實用內科雜志, 2017, 37(1): 28-34.
|
| 16. |
Romanowski K, Clark EG, Levin A, et al. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int, 2016, 90(1): 34-40.
|
| 17. |
海珊, 鐘慧, 劉芳, 等. 慢性腎臟疾病合并結核 40 例臨床分析. 四川醫學, 2007, 28(5): 501-502.
|
| 18. |
Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998–2000. Am J Transplant, 2004, 4: 1523-1528.
|
| 19. |
Zuo L, Wang M. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol, 2010, 74: S20-S22.
|
| 20. |
Carrero JJ, Stenvinkel P. Infammation in end-stage renal disease-what have we learned in 10 years?. Semin Dial, 2010, 23: 498-509.
|
| 21. |
李亮. 從臨床醫生的角度看結核病診斷技術. 中華臨床醫師雜志(電子版), 2014, 8(23): 4165-4168.
|
| 22. |
Al Jahdali H, Ahmed AE, Balkhy HH, et al. Comparison of the tuberculin skin test and Quanti-FERON-TB Gold In-Tube (QFT-G) test for the diagnosis of latent tuberculosis infection in dialysis patients. J Infect Public Health, 2013, 6(3): 166-172.
|
| 23. |
Ferguson TW, Tangri N, Macdonald K, et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. Transplantation, 2015, 99: 1084-1091.
|
| 24. |
陳雪融, 唐小燕. γ-干擾素釋放試驗研究進展. 現代臨床醫學, 2016, 42(5): 397-400.
|
| 25. |
秦慶, 胡瑛, 呂永強. 痰涂片抗酸染色、結核抗體試驗、熒光 PCR、T-SPOT.TB 在肺結核診斷中的臨床意義. 中國醫藥科學, 2017, 7(21): 130-133.
|
| 26. |
賀晨艷, 石海萍, 韓莉, 等. TB-PCR、Xpert MTB/RIF、T-SPOT 釋放試驗診斷結核感染的臨床應用研究. 醫學信息上旬刊, 2014, (4): 107-108.
|
| 27. |
張小剛, 莊玉輝, 何秀云, 等. 重組結核分支桿菌 38kD 和 16kD 蛋白用于結核病血清學診斷的價值. 中國防癆雜志, 2001, 23(5): 281-283.
|
| 28. |
錢東林. 蛋白芯片檢測結核分枝桿菌對肺結核病的臨床診斷價值. 標記免疫分析與臨床, 2013, 20(5): 352-353.
|
| 29. |
簡奕孌, 古卓云, 魏琳, 等. 抗結核藥物性視神經炎的臨床分析. 國際眼科雜志, 2014, 14(9): 1705-1706.
|